Cypher AI (cypherbio.ai), a Cambridge, MA-based platform that lets scientists generate adaptive ELN, LIMS and analysis tools via natural language, has raised $2M in seed funding led by MaC Venture Capital. The system creates and updates production-grade lab infrastructure in real time as experiments evolve, eliminating manual configuration. The capital will accelerate product development and customer expansion.
AI Infrastructure Wave Hits Biotech Labs
The timing aligns with a broader shift toward AI-native systems in life sciences. Benchling raised $200M Series E to expand its cloud platform. Cypher's natural-language approach targets the gap between rigid legacy tools and fast-changing biology workflows.
Legacy LIMS Fail Dynamic Biology Workflows
Traditional systems require hundreds of clicks and static configurations that cannot keep pace with evolving experiments. Biotech teams lose reproducibility and context when moving between design, execution and analysis. This friction slows development cycles across early-stage discovery through manufacturing.
Natural Language Replaces Static Configuration
Cypher generates custom analysis pipelines, sample tracking and instrument integrations on demand. Unlike Benchling or Sapio Sciences, which rely on pre-built templates, the platform adapts workflows automatically and compounds institutional knowledge from each dataset. Early customers including Ginkgo Bioworks alumni companies report faster iteration without IT overhead.
"Modern biology isn't slow. Our digital infrastructure is."
Mission and Technical Investors Back Thesis
MaC Venture Capital led the round with participation from Epsilon Ventures, Connecticut Innovations, Sparta Group and LiquidMetal Ventures. MaC's focus on founder-led, category-defining companies pairs with Epsilon's technical AI emphasis and Connecticut Innovations' life sciences mandate, signaling strategic validation for AI infrastructure in R&D.
$2.73B Market Expands to $15.94B by 2035
The AI-in-life-sciences market stands at $2.73 billion in 2025 and is projected to reach $15.94 billion by 2035 at 19.3% CAGR. Structural drivers include exploding biology data volumes and the need for connected, AI-ready data platforms. Conferences such as Bio-IT World 2026 underscore the urgency for operational AI systems.
Ex-Ginkgo Team Brings Production Expertise
Founder Yaoyu Yang previously worked at Ginkgo Bioworks. The company recently hired Jamie Cho, former Head of Software at Ginkgo, as Vice President of Engineering. Advisors include Rahul Singhvi, ex-Resilience COO, and Benjie Chen, Addgene co-founder.
Marketplace Rollout Targets CROs and Service Providers
Cypher is extending the platform with a marketplace for orders, coordination and execution. The move opens the system to CROs and service providers while deepening integrations with instruments such as the Echo Acoustic Liquid Handler.